By adjusting the sequencing of currently available treatments, improved compliance with therapy is ensured, and novel scientific and clinically relevant hypotheses can be further explored.
Mark S. Roh, MD, MMM
Advertisement
Articles by Mark S. Roh, MD, MMM
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Belzutifan Combo Improves Disease Control Vs Cabozantinib in Advanced RCC
2
Lymphoma's Revolution: Evens & Rhodes on CLL, CAR-T, and NJ Care
3
Making Nuanced Decisions on CAR-T and Bispecifics in Multiple Myeloma
4
Choosing Between Approved Frontline Metastatic Pancreatic Cancer Regimens
5